ACM
Allred Capital Management Portfolio holdings
AUM
$267M
This Quarter Return
+8.58%
1 Year Return
+15.69%
3 Year Return
+60.07%
5 Year Return
+117.66%
10 Year Return
–
AUM
$165M
AUM Growth
+$165M
(+4.9%)
Cap. Flow
+$966K
Cap. Flow
% of AUM
0.58%
Top 10 Holdings %
Top 10 Hldgs %
37.96%
Holding
172
New
12
Increased
62
Reduced
79
Closed
10
Top Buys
| 1 |
Apple
AAPL
|
$4.12M |
| 2 |
Invesco S&P 500 Equal Weight Technology ETF
RSPT
|
$988K |
| 3 |
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
|
$383K |
| 4 |
Lam Research
LRCX
|
$308K |
| 5 |
General Dynamics
GD
|
$301K |
Top Sells
| 1 |
Technology Select Sector SPDR Fund
XLK
|
$1.05M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
$591K |
| 3 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
$458K |
| 4 |
Amazon
AMZN
|
$422K |
| 5 |
Tyler Technologies
TYL
|
$419K |
Sector Composition
| 1 | Technology | 19.91% |
| 2 | Healthcare | 12.43% |
| 3 | Industrials | 9.34% |
| 4 | Consumer Staples | 8.55% |
| 5 | Financials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Novartis
NVS
$244B
| $283K | 0.17% |
3,258
-12
| -0.4% | -$1.04K |
|
127
Labcorp
LH
$22.8B
| $281K | 0.17% |
1,497
-1
| -0.1% | -$188 |
|
128
TJX Companies
TJX
$154B
| $277K | 0.17% |
4,988
+174
| +4% | +$9.66K |
|
129
Progressive
PGR
$144B
| $275K | 0.17% |
2,905
-85
| -3% | -$8.05K |
|
130
Aflac
AFL
$56.4B
| $271K | 0.16% |
7,476
+42
| +0.6% | +$1.52K |
|
131
Schlumberger
SLB
$53.5B
| $265K | 0.16% |
17,045
-195
| -1% | -$3.03K |
|
132
iShares MSCI USA Momentum Factor ETF
MTUM
$18B
| $262K | 0.16% |
1,780
-6
| -0.3% | -$883 |
|
133
GE Aerospace
GE
$292B
| $260K | 0.16% |
41,765
+123
| +0.3% | +$766 |
|
134
Mondelez International
MDLZ
$79.5B
| $257K | 0.16% |
4,475
-2
| -0% | -$115 |
|
135
PPG Industries
PPG
$24.7B
| $256K | 0.15% |
2,100
-18
| -0.8% | -$2.19K |
|
136
NXP Semiconductors
NXPI
$58.3B
| $253K | 0.15% |
+2,031
| New | +$253K |
|
137
Becton Dickinson
BDX
$54.1B
| $252K | 0.15% |
1,085
+37
| +4% | +$8.59K |
|
138
Edwards Lifesciences
EW
$48.1B
| $249K | 0.15% |
+3,123
| New | +$249K |
|
139
IQVIA
IQV
$31.4B
| $244K | 0.15% |
1,549
+90
| +6% | +$14.2K |
|
140
American Express
AXP
$230B
| $239K | 0.14% |
2,390
-300
| -11% | -$30K |
|
141
Chubb
CB
$110B
| $239K | 0.14% |
2,060
+111
| +6% | +$12.9K |
|
142
iShares Biotechnology ETF
IBB
$5.69B
| $237K | 0.14% |
1,755
+125
| +8% | +$16.9K |
|
143
Blackrock
BLK
$172B
| $229K | 0.14% |
408
-1
| -0.2% | -$561 |
|
144
Target
TGT
$42B
| $228K | 0.14% |
+1,452
| New | +$228K |
|
145
iShares US Technology ETF
IYW
$22.6B
| $224K | 0.14% |
745
+1
| +0.1% | +$301 |
|
146
DuPont de Nemours
DD
$31.7B
| $223K | 0.13% |
4,026
+153
| +4% | +$8.48K |
|
147
Simmons First National
SFNC
$3B
| $218K | 0.13% |
13,770
| – | – |
|
148
T Rowe Price
TROW
$23.1B
| $217K | 0.13% |
1,697
+9
| +0.5% | +$1.15K |
|
149
Bank of America
BAC
$372B
| $214K | 0.13% |
8,885
-456
| -5% | -$11K |
|
|
ETV
150
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.62B
| $214K | 0.13% |
+15,500
| New | +$214K |
|